JHS Svendgaard Laboratories Ltd Financials
Company Logo

JHS Svendgaard Laboratories Ltd Financial Statement

JHS Svendgaard Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue24.80
Operating Expense22.51
Net Profit-0.63
Net Profit Margin-2.54
Earning Per Share-0.08
EBIDTA1.63
Effective Tax Rate7.42

JHS Svendgaard Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual70.80
Operating Expenses Annual71.73
Operating Profit Annual3.38
Interest Annual0.46
Depreciation6.21
Net Profit Annual-4.05
Tax Annual0.63

JHS Svendgaard Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning37.22
Cash Flow from Operations-8.58
Cash Flow from Investing-21.95
Cash Flow from Financing2.17
Cash Flow at the End8.87

JHS Svendgaard Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)4.77
PBIT Margin (%)-4.19
PBT Margin (%)4.89
Net PROFIT Margin (%)-5.72
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-2.29
Total Debt / Equity (X)0.02
Asset Turnover Ratio (%)0.40

JHS Svendgaard Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual90.41
Total Current Assets Annual43.42
Non Current Assets Annual154.03
Total Shareholders Funds Annual170.28
Total Assets Annual197.45

JHS Svendgaard Laboratories Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-0.08

Surprise

0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Sep 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 5, 2024, JHS Svendgaard Laboratories Ltd has a market capitalization of 128.49 Cr. Value Research classifies it as a Micro-Cap company.
Yes, JHS Svendgaard Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , JHS Svendgaard Laboratories Ltd recorded a total revenue of approximately 70.80 Cr marking a significant milestone in the company's financial performance.
JHS Svendgaard Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and -0.1% annually, respectively..
JHS Svendgaard Laboratories Ltd's current PE ratio is -31.73.
JHS Svendgaard Laboratories Ltd's ROCE averaged -0.8% from the FY ending March 2022 to 2024, with a median of -1.7%. It peaked at 1.3% in March 2022, reflecting strong capital efficiency over the period..
JHS Svendgaard Laboratories Ltd's latest EBIT is Rs. -2.96 Cr, surpassing the average EBIT of Rs. -7.65 Cr over the 5 years..